digibusiness.fi | healthcarebusiness.fi | nanobusiness.fi | swbusiness.fi

Business cases for Hermo Pharma Ltd.

Why?

  • To strengthen your networks outside academia.
  • To get into a company’s playing field.
  • To learn what the business terminology means in practice.
  • To become assured that your knowledge and skills are extremely valuable.
  • To have a look at the managers’ and directors’ daily work in a drug development company.

 

For whom?

The course is aimed at PhD students in the life science sector. Students will be accepted primarily from the participating doctoral programs (FGNS, FICS, GPBM, HBGS and VGSB) and FIMM but also other students can be accepted. All participants are expected to sign in CDA/NDA.

 

How?

  • The business cases (~ 40 hours of work) will be prepared in teams of 5-6 students during February and March.
    The course starts with a two day introduction, lectures and assignment
  • Each team member will be responsible of one business area (market / product / IPR / partners / financing / contracts and risks), but everyone will participate in and learn about all areas.
  • An external expert as well as the employees of  Hermo Pharma Ltd. will guide the students’ work to ensure that both the company and the students benefit from the project.
  • In the end each group will present their business case. The best work will be rewarded!

 

Timetable

  1. Introduction and commission: 16.2. at 9-15, Viikki Korona information center, lecture hall 4
  2. Lectures: 17.2. at 9-16, Viikki Biocenter 2, Lecture hall 2063
  3. Weekly 1,5 hour appointments with a consultant.
  4. Financial calculations: 7.3. at 8-15, Viikki Biocenter 3  Lecture hall 2402
  5. Presentation and evaluation of the business cases: 28.3. at 12-16, Viikki Biocenter 2, Lecture hall 1015.

 

For more information, please contact Kati Takaluoma: kati.takaluoma(at)culminatum.fi